|
KLHL11 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.163700E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.719500E-03 |
| Normal-vs-Stage2 |
7.840000E-02 |
| Normal-vs-Stage3 |
9.045600E-02 |
| Normal-vs-Stage4 |
4.043700E-02 |
| Stage1-vs-Stage2 |
7.614600E-01 |
| Stage1-vs-Stage3 |
7.427800E-01 |
| Stage1-vs-Stage4 |
8.148800E-01 |
| Stage2-vs-Stage3 |
9.886600E-01 |
| Stage2-vs-Stage4 |
6.388400E-01 |
| Stage3-vs-Stage4 |
6.597400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.096700E-03 |
| Normal-vs-AfricanAmerican |
3.603000E-03 |
| Normal-vs-Asian |
1.420530E-03 |
| Caucasian-vs-AfricanAmerican |
5.360800E-01 |
| Caucasian-vs-Asian |
2.552300E-02 |
| AfricanAmerican-vs-Asian |
7.127600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.022700E-04 |
| Normal-vs-Female |
9.390000E-01 |
| Male-vs-Female |
1.535440E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.018980E-01 |
| Normal-vs-Extreme_Weight |
1.215120E-04 |
| Normal-vs-Obese |
3.033700E-02 |
| Normal-vs-Extreme_Obese |
8.178400E-03 |
| Normal_Weight-vs-Extreme_Weight |
2.051400E-01 |
| Normal_Weight-vs-Obese |
9.093200E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.807200E-01 |
| Extreme_Weight-vs-Obese |
7.125600E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.455400E-01 |
| Obese-vs-Extreme_Obese |
3.381000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.384790E-01 |
| Normal-vs-Age(41-60Yrs) |
1.199370E-01 |
| Normal-vs-Age(61-80Yrs) |
6.17729999999872E-05 |
| Normal-vs-Age(81-100Yrs) |
8.824300E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.962600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.879600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.589040E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.659830E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.466400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.312400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.769700E-04 |
| Normal-VS-Type2 PRCC |
1.385940E-02 |
| Normal-VS-KIRP CIMP |
6.727400E-01 |
| Normal-VS-Unclassified PRCC |
8.484200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.068600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.444400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.291870E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.447000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.996200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
7.966400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.97750999999524E-05 |
| Normal-vs-N1 |
2.955000E-01 |
| Normal-vs-N2 |
1.305640E-01 |
| N0-vs-N1 |
9.185900E-02 |
| N0-vs-N2 |
6.873800E-01 |
| N1-vs-N2 |
6.377800E-01 |
|
|
